Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT02247141Phase 3Completed
A Phase 3 trial of Subgam in Primary antibody deficiency (PAD), sponsored by Bio Products Laboratory. Started Jun 2000; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT02247141.